Skerritt J H, Johnston G A, Katsikas T, Tabar J, Nicholson G M, Andrews P R
Neurochem Res. 1983 Oct;8(10):1337-50. doi: 10.1007/BF00964002.
The effects of a variety of factors known to influence the enhancement of GABA binding by diazepam, were studied upon pentobarbitone stimulation of GABA binding to washed synaptosomal membranes prepared from whole rat brains. The differential kinetics of, and effects of temperature, chloride ions, a benzodiazepine receptor antagonist (Ro15-1788) and picrotoxinin upon pentobarbitone and diazepam enhancement of GABA binding, suggest that these drugs exert their actions upon GABA binding at different loci. The degree of enhancement of diazepam binding and of high affinity GABA binding in chloride-containing media at 25 degrees C by members of a series of twelve side chain methyl substituted and/or unsaturated derivatives of 5-butyl-5-ethyl-barbituric acid (pentobarbitone analogs) correlated significantly. For the sedative members of the series, enhancement of high affinity GABA binding correlated with their anaesthetic but not their anticonvulsant activities. It appears likely that the anaesthetic and anticonvulsant activities of barbiturates arise from different molecular actions.
已知多种因素会影响地西泮对γ-氨基丁酸(GABA)结合的增强作用,本研究观察了这些因素对戊巴比妥刺激GABA与从大鼠全脑制备的洗涤突触体膜结合的影响。温度、氯离子、苯二氮䓬受体拮抗剂(Ro15 - 1788)和匹鲁卡品对戊巴比妥和地西泮增强GABA结合的差异动力学及影响表明,这些药物在不同位点对GABA结合发挥作用。在25℃含氯离子的介质中,一系列12种5-丁基-5-乙基巴比妥酸侧链甲基取代和/或不饱和衍生物(戊巴比妥类似物)对GABA结合和地西泮结合的增强程度显著相关。对于该系列中的镇静剂成员,高亲和力GABA结合的增强与其麻醉活性相关,而与其抗惊厥活性无关。巴比妥类药物的麻醉和抗惊厥活性似乎源于不同的分子作用。